US Stock MarketDetailed Quotes

PXMD PaxMedica

Watchlist
  • 0.031
  • 0.0000.00%
15min DelayTrading Jan 22 16:00 ET
337.25KMarket Cap-0.01P/E (TTM)

About PaxMedica Company

PaxMedica, Inc. is a clinical stage biopharmaceutical company. It engages in the business of developing drug candidates for the treatment of autism spectrum disorder, Fragile X syndrome tremor-ataxia, and Human African Trypanosomiasis. The company was founded by Michael L. Derby on April 5, 2018 and is headquartered in Tarrytown, NY.

Company Profile

SymbolPXMD
Company NamePaxMedica
Listing DateAug 26, 2022
Issue Price5.25
Founded2018
CEOMr. Howard J. Weisman
MarketPink Market
Employees7
Fiscal Year Ends12-31
Address303 South Broadway,Suite 125
CityTarrytown
ProvinceNew York
CountryUnited States of America
Zip Code10591
Phone1-914-987-2876

Company Executives

  • Name
  • Position
  • Salary
  • Howard J. Weisman
  • Chief Executive Officer and Chairman of the Board
  • 1.05M
  • Dr. David W. Hough, M.D.
  • Chief Medical Officer
  • 266.78K
  • Stephen D. Sheldon
  • Chief Financial Officer, Principal Accounting Officer and Chief Operating Officer
  • 635.87K
  • Zachary Rome
  • Director
  • 322.23K
  • Karen LaRochelle
  • Independent Director
  • 83.31K
  • Charles J. Casamento
  • Lead Independent Director
  • 98.83K
  • Dr. John F. Coelho
  • Independent Director
  • 79.47K

Trending Stocks

Discussing
Big Tech’s earnings season kicks off: How will market react?
🎙️ Discussion: 1. Can Big Tech earnings lead all sectors higher again? 2. How will the tech giants be affected by the "Trump Factor"? Show More